Breaking

Forge Encounters Coal Seam amid Rising Coal Prices and Completes Resin Injections at La Estrella, Colombia
Signing of Share Subscription Agreement with Quorium Global Photonics SPC (“QGP”),
Sankamap Advances Toward Inaugural Drilling at Kuma Property in the Solomon Islands
Gold Price Hits New Record, Soaring Over US$4,800
Homeland Nickel Provides Corporate Update
Angkor Resources’ Subsidiary Identifies Drill Targets On Block VIII Oil & Gas, Cambodia
Fortune Minerals Completes Cobalt Sulphate Test Work
LaFleur Minerals Inc.Stands Out with Rare Combo of Assets, Infrastructure

Facebook
Twitter
Google Plus
Instagram
Pinterest
Vimeo

Investing
Stock
Latest News
Editor’s Pick
Economy
Search for:

Investing

Completion of preclinical data package for RAD 402

By December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Forge Encounters Coal Seam amid Rising Coal Prices and Completes Resin Injections at La Estrella, Colombia

January 21, 2026

Signing of Share Subscription Agreement with Quorium Global Photonics SPC (“QGP”),

January 21, 2026

Sankamap Advances Toward Inaugural Drilling at Kuma Property in the Solomon Islands

January 21, 2026

Enter Your Information Below To Receive Latest News, And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest Posts
Categories
- Economy (1,041)
- Editor's Pick (702)
- Investing (5,848)
- Latest News (3,536)
- Stock (1,161)
About Rightinvestingway

Disclaimer: Rightinvestingway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Rightinvestingway.com

Top

Type above and press Enter to search. Press Esc to cancel.